Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

C-SWIFT Study: elbasvir/grazoprevir + SOF
C-SWIFT Study: elbasvir/grazoprevir + SOF
by myesha-ticknor
in genotypes 1 or 3, with or without cirrhosis. &...
C-SWIFT Study: elbasvir/grazoprevir + SOF
C-SWIFT Study: elbasvir/grazoprevir + SOF
by pamella-moone
in genotypes 1 or 3, with or without cirrhosis. &...
Treatment regimens
Treatment regimens
by mitsue-stanley
Co-formulated . ombitasvir. (OBV)/. paritaprevir...
Treatment regimens
Treatment regimens
by natalia-silvester
Co-formulated . ombitasvir. (OBV)/. paritaprevir...
Not randomised Open-label
Not randomised Open-label
by cheryl-pisano
18-70 years. HCV genotype 1 or 3. Naïve or failu...
≥ 18 years HCV genotype 1, 2, 4, 5, 6
≥ 18 years HCV genotype 1, 2, 4, 5, 6
by alexa-scheidler
HCV RNA ≥ 1000 IU/mL. Treatment-naïve or treat...
Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology
Andrew J. Muir, MD, MHS Chief, Division of Gastroenterology
by badra
Duke University School of Medicine. Durham, North ...
Hepatitis C Imtiaz Alam, M.D.
Hepatitis C Imtiaz Alam, M.D.
by olivia-moreira
Medical Director, Austin Hepatitis Center. 1. Hep...
CRONIC HEPATITIS, CIRRHOSIS, HEPATIC FAILURE
CRONIC HEPATITIS, CIRRHOSIS, HEPATIC FAILURE
by tawny-fly
ASSOC. PROF. DR. INGRID MIRON. What is Viral Hepa...
No randomisation
No randomisation
by tatiana-dople
N = 100. W12. W24. Arm B: . compensated cirrhosis...
C-SALT Study:
C-SALT Study:
by marina-yarberry
grazoprevir. . + . elbasvir. . in genotype 1 wi...
Sofosbuvir-Velpatasvir in Genotype 2
Sofosbuvir-Velpatasvir in Genotype 2
by stefany-barnette
ASTRAL-2*. Phase 3. . Treatment. . Naïve &...
National Hepatitis C Database
National Hepatitis C Database
by HappyHippie
Dr Lelia Thornton. Health Protection . Surveillanc...
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With HCV Genotype 3 Infection:
by kittie-lecroy
Interim Analysis of a French Multicenter Compassi...
www.hcvadvocate.org BLOG: hcvadvocate.blogspot.com
www.hcvadvocate.org BLOG: hcvadvocate.blogspot.com
by luanne-stotts
. HCV Training Workshop. Version 19.0. HCSP/HCV ...
SOF + RBV
SOF + RBV
by debby-jeon
SOF + RBV. Randomisation*. 1 : 1 : 1. Open-label....
C-WORTHY/B
C-WORTHY/B
by stefany-barnette
Randomisation*. Open-label. >. 18 years. HCV ...
No randomisation
No randomisation
by pamella-moone
Open-label. 18-70 years. HCV genotype 1. Naïve o...
Sofosbuvir-Velpatasvir
Sofosbuvir-Velpatasvir
by jane-oiler
(. Epclusa. ). Prepared by. : H. Nina Kim, MD MS...
Randomisation
Randomisation
by pamella-moone
*. 1:1. Open-label. ≥ 18 years. HCV genotype ...
SIRIUS
SIRIUS
by tawny-fly
Placebo. LDV/SOF + placebo. Randomisation*. 1 : 1...
SOF/VEL
SOF/VEL
by trish-goza
400/100 mg . qd. N = 120. N = 120. W12. SOF + RBV...